GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets Hard-to-Treat tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug called RYZ401 in people with neuroendocrine tumors and other solid tumors that have a specific marker (somatostatin receptors). The main goals are to find the safest dose and schedule, and to see if the drug can shrink tumors or…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 01, 2026 14:31 UTC
-
New study tracks PRRT effects on neuroendocrine tumors
Disease control Recruiting nowThis study is gathering information on how well peptide receptor radionuclide therapy (PRRT) works for people with neuroendocrine tumors that started in the stomach, intestines, or pancreas. Researchers will track patient details, tumor changes, survival, and side effects. The go…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Methodist Health System • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New hope for rare cancers: immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (domvanalimab and zimberelimab) in people with five types of rare advanced cancers that have not responded to standard treatment. The goal is to see if this treatment can control the cancer for at least 24 weeks. About 154…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
New study aims to predict which patients benefit from targeted radiation therapy
Knowledge-focused Recruiting nowThis study will follow 80 people with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who are receiving peptide receptor radionuclide therapy (PRRT). Researchers will use advanced PET-MRI scans and genetic profiling before, during, and after treatment to find pat…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 01, 2026 14:34 UTC
-
Could your diet change the course of a Slow-Growing cancer?
Knowledge-focused Recruiting nowThis study looks at how nutrition is linked to the health of adults with gastroenteropancreatic neuroendocrine tumors (NETs), a slow-growing cancer of the digestive system. Researchers will check 100 patients for signs of malnutrition and see if it affects their prognosis. The go…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC